Results 171 to 180 of about 87,437 (368)

Inhibition of Adjuvant-Induced Polyarthritis with Cytarabine

Experimental Biology and Medicine, 1968
Discussion and SummaryCytarabine, like other cytotoxic drugs, inhibits the onset of adjuvant-induced polyarthritis. Both steroidal and nonsteroidal “anti-inflammatory” drugs inhibit the severity of adjuvant-induced polyarthritis 6, 7, 20. The steroids are more effective, since they inhibit not only the onset and development of the disease, but also ...
openaire   +3 more sources

Advancements in genetic analysis: Insights from a case study and review of next‐generation sequencing techniques for veterinary oncology applications

Veterinary Clinical Pathology, EarlyView.
Abstract Acute myeloid leukemia (AML) poses significant challenges in veterinary medicine, with limited treatment options and poor survival rates. While substantial progress has been made in characterizing human AML, translating these advancements to veterinary practice has been hindered by limited molecular understanding and diagnostic tools. The case
R. Adam Harris, Jillian Nolan, Dylan Ammons, Samantha Beeson, Douglas Thamm, Anne Avery   +5 more
wiley   +1 more source

Extended Infusions of Meropenem for Febrile Neutropenia [PDF]

, 2019
Background: Neutropenic fever is an oncologic emergency that requires quick intervention with anti-pseudomonal beta-lactam antibiotics, such as meropenem.
Przybylski, PharmD, Daniel J, Reeves, PharmD, BCOP, David J   +1 more
core   +1 more source

Long‐Term Real‐World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results

Hematological Oncology, Volume 43, Issue 6, November 2025.
ABSTRACT Primary central nervous system lymphomas (PCNSL) are rare malignancies with poor survival outcomes. The IELSG32 trial demonstrated efficacy of MATRix chemoimmunotherapy followed by autologous stem cell transplantation (auto‐SCT) in PCNSL patients aged ≤ 70 years with a performance status (PS) ECOG ≤ 3.
Prokop Vodicka, Andrea Janikova, David Belada, Veronika Hanackova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Katerina Benesova, Eva Konirova, Tomas Prochazka, Kamila Polgarova, Michal Masar, Jitka Dlouha, Petra Blahovcova, Marek Trneny   +14 more
wiley   +1 more source

Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway

Drug Design, Development and Therapy, 2017
Kai-Hong Zhao,1 Can Zhang,2 Yue Bai,1 Yan Li,1 Xun Kang,1 Jian-Xin Chen,1 Kun Yao,3 Tao Jiang,4 Xiao-Song Zhong,2 Wen-Bin Li1 1Department of Glioma, 2Clinical Center of Gene And Cell Engineering, Beijing Shijitan Hospital, 3Department of Neurosurgery ...
Zhao KH, Zhang C, Bai Y, Li Y, Kang X, Chen JX, Yao K, Jiang T, Zhong XS, Li WB   +9 more
doaj  

THE IMMUNOSUPPRESSIVE ACTIVITY OF ARA-CYTIDINE (CYTARABINE)

, 1969
Gary D. Gray, R. J. Perper, M.M. Mickelson, John A. Crim, C F Zukowski   +4 more
openalex   +1 more source

Feasibility of an Intravenous Home Chemotherapy Intervention With Low‐Dose Cytarabine Administered by Parents (INTACTatHome)

Pediatric Blood &Cancer, Volume 72, Issue 11, November 2025.
ABSTRACT Background: Intravenous home chemotherapy (IHC) can reduce the frequency of hospital visits and positively affect the child's and the family's everyday life. Knowledge about IHC is needed to enhance evidence‐based provision and implementation. This study aimed to evaluate the feasibility of an IHC intervention.
Louise Ingerslev Roug, Lisa Lyngsie Hjalgrim, Tenna Ruest Haarmark Nielsen, Martha Krogh Topperzer, Mary Jarden, Anders Tolver, Astrid Eliasen, Ayo Wahlberg, Rikke Thenning Michelsen, Helena Hansson   +9 more
wiley   +1 more source

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia [PDF]

, 1999
Martin S. Tallman, Charles Lee, Branimir I. Šikić, Elisabeth Paietta, Peter H. Wiernik, J. McL. Bennett, Jacob M. Rowe   +6 more
openalex   +1 more source

Evaluating the Implementation Success of an Intensity‐Adapted Guideline for Pediatric Acute Myeloid Leukemia in Malawi: An Observational‐Implementation Study Protocol

Pediatric Blood &Cancer, Volume 72, Issue 11, November 2025.
ABSTRACT Acute myeloid leukemia (AML) is most often incurable in low‐resource settings. To address this challenge, the International Society of Paediatric Oncology (SIOP) developed an intensity‐adapted AML practice guideline in 2019. Here, we present the protocol of an observational‐implementation study evaluating the SIOP guideline in Malawi.
Noel Mwango, Grace Chirwa, Dennis Phalula, Rizine Mzikamanda, Nmazuo Ozuah, Shaun Bulsara, Susan Hilsenbeck, Mina Hosseinipour, Gertjan J. L. Kaspers, Rachel Rau, Jane Montealegre, Carl E. Allen, Casey L. McAtee   +12 more
wiley   +1 more source

Varicella-Zoster Virus and Subcutaneous Cytarabine: Correlation of In Vitro Sensitivities to Blood Levels

, 1975
Dawlat A. Zaky, Robert F. Betts, R. Gordon Douglas, Kathleen Bengali, G L Neil   +4 more
openalex   +1 more source